z-logo
Premium
EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells
Author(s) -
Hu HsienMing,
ZielinskaKwiatkowska Anna,
Munro Karen,
Wilcox Jason,
Wu Daniel Y.,
Yang Liu,
Chansky Howard A.
Publication year - 2008
Publication title -
journal of orthopaedic research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 155
eISSN - 1554-527X
pISSN - 0736-0266
DOI - 10.1002/jor.20597
Subject(s) - cyclin d1 , fli1 , gene knockdown , retinoblastoma protein , retinoblastoma , senescence , cancer research , fusion protein , ewing's sarcoma , biology , phenotype , cyclin , microbiology and biotechnology , cell cycle , gene , transcription factor , genetics , recombinant dna , chemotherapy
Ewing's Family Tumors (EFTs) most commonly harbor a specific t(11;22) translocation that generates the EWS/FLI1 fusion protein responsible for malignant transformation. Many potential downstream targets of EWS/FLI1 have been identified but a detailed mechanism by which the fusion protein brings about transformation remains unknown. In this report, we show that depletion of EWS/FLI1 in Ewing's cell lines results in a senescence phenotype, a marked increase in expression of the G1/S regulatory proteins p27 kip1 and p57 kip2 , and a significant decrease in cyclin D1 and CDK2. We also demonstrate for the first time, to our knowledge, that knockdown of EWS/FLI1 leads to hypophosphorylation and functional activation of the retinoblastoma (pRb) family of proteins. Consistent with activation of the pRb proteins, E2F‐responsive genes such as cyclin A are repressed in EWS/FLI1‐depleted cells. Together, these results support the role of EWS/LI1 as an inhibitor of cellular senescence and implicate the retinoblastoma family of proteins as key mediators of this inhibition. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:886–893, 2008

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom